Work

Supplementary table S3 from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer

Year: 2025

Type: supplementary-materials

Abstract: Supplementary Table S3. The spectral NMR (proton and carbon) data for HBS-101 NMR spectra. NMR spectra were recorded on a Bruker Avance II and AV (500 MHz and 300MHz) spectrometers as deuterochloroform (CDCl3) solutions.

DOI: 10.1158/1535-7163.30028846

Authors: Megharani Mahajan, Alondra L. Rodriguez Sanchez, Sridharan Jayamohan, Dileep K. Vijayan, Jessica D. Johnson, Huan Xie, Yang Wang, Dong Liang, John R. Sanchez, Panneerdoss Subbarayalu, Manjeet K. Rao, Ratna K. Vadlamudi, Gangadhara R. Sareddy, Hareesh B. Nair, Suryavathi Viswanadhapalli

Language: English

Topic: Cancer Mechanisms and Therapy

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4413905590

Cites:

Cited by:

Related to: 10